Nautilus Biotechnolgy
NAUT
83 hedge funds and large institutions have $183M invested in Nautilus Biotechnolgy in 2024 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
77% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 13
22% more capital invested
Capital invested by funds: $150M → $183M (+$33.2M)
8% more funds holding
Funds holding: 77 → 83 (+6)
0.09% more ownership
Funds ownership: 51.09% → 51.18% (+0.09%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$303K |
| 2 |
Goldman Sachs
New York
|
+$206K |
| 3 |
Morgan Stanley
New York
|
+$204K |
| 4 |
Barclays
London,
United Kingdom
|
+$122K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$679K |
| 2 |
Bank of New York Mellon
New York
|
-$94.8K |
| 3 |
Jane Street
New York
|
-$64.8K |
| 4 |
CC
Clearline Capital
New York
|
-$51.5K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$29.8K |
NAUT Hedge Fund Activity: Q3 2024 in Review
83 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Nautilus Biotechnolgy (NAUT) for Q3 2024, worth a combined $183M — up 22% from $150M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new NAUT positions and 2 closed out — a net gain of 6 holders — while 23 added to existing stakes and 13 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $303K. The largest seller was BlackRock, cutting an estimated $679K.
- 83 institutional investors held Nautilus Biotechnolgy (NAUT) as of Q3 2024, up from 77 in Q2 2024.
- Funds reported $183M of Nautilus Biotechnolgy stock for Q3 2024, up 22% quarter-over-quarter.
- 8 funds opened new Nautilus Biotechnolgy positions in Q3 2024 and 2 closed out, a net change of +6 holders.
- The largest Nautilus Biotechnolgy buyer in Q3 2024 was Dimensional Fund Advisors, an estimated $303K added.
- The largest Nautilus Biotechnolgy seller in Q3 2024 was BlackRock, an estimated $679K sold.
Based on aggregated 13F filings for Q3 2024.